{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05808764",
            "orgStudyIdInfo": {
                "id": "BN44619"
            },
            "secondaryIdInfos": [
                {
                    "id": "2023-505602-42-00",
                    "type": "REGISTRY",
                    "domain": "EU CT Number"
                }
            ],
            "organization": {
                "fullName": "Hoffmann-La Roche",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study to Investigate the Pharmacokinetics and Safety of Risdiplam in Infants With Spinal Muscular Atrophy",
            "officialTitle": "A Phase II, Open-label Study to Investigate the Pharmacokinetics and Safety of Risdiplam in Infants With Spinal Muscular Atrophy",
            "acronym": "PUPFISH",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-study-to-investigate-the-pharmacokinetics-and-safety-of-risdiplam-in-infants-with-spinal-muscular-atrophy"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-04-26",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-08-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-08-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-03-30",
            "studyFirstSubmitQcDate": "2023-03-30",
            "studyFirstPostDateStruct": {
                "date": "2023-04-11",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-04",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-05",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Hoffmann-La Roche",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study will evaluate the pharmacokinetics (PK) and safety of risdiplam in participants with spinal muscular atrophy (SMA) under 20 days of age at first dose."
        },
        "conditionsModule": {
            "conditions": [
                "Muscular Atrophy, Spinal"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 10,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Risdiplam",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive risdiplam once daily for 28 days.",
                    "interventionNames": [
                        "Drug: Risdiplam"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Risdiplam",
                    "description": "Participants will receive 0.15 mg/kg risdiplam orally once daily for 28 days.",
                    "armGroupLabels": [
                        "Risdiplam"
                    ],
                    "otherNames": [
                        "Evrysdi"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Plasma Concentrations of Risdiplam",
                    "timeFrame": "From Day 1 through Day 28"
                },
                {
                    "measure": "Area Under the Plasma Concentration-Time Curve (AUC) of Risdiplam",
                    "timeFrame": "From Day 1 through Day 28"
                },
                {
                    "measure": "Steady-state Concentration (Css) of Risdiplam",
                    "timeFrame": "From Day 1 through Day 28"
                },
                {
                    "measure": "Risdiplam Free Fraction",
                    "timeFrame": "From Day 1 through Day 28"
                },
                {
                    "measure": "Percentage of Participants With Adverse Events",
                    "timeFrame": "Up to 30 days after the final dose of study treatment (up to 58 days)"
                },
                {
                    "measure": "Percentage of Participants With Serious Adverse Events",
                    "timeFrame": "Up to 30 days after the final dose of study treatment (up to 58 days)"
                },
                {
                    "measure": "Percentage of Participants With Treatment Discontinuation due to Adverse Events",
                    "timeFrame": "Up to 30 days after the final dose of study treatment (up to 58 days)"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Male or female newborn infant aged \\<20 days at first dose\n* Newborn infants with genetic diagnosis of 5q-autosomal recessive SMA or newborn infants identified as positive for SMA via newborn screening or via prenatal testing.\n* Gestational age equal to or greater than 37 weeks\n* Receiving adequate nutrition and hydration at the time of screening\n* Adequately recovered from any acute illness at baseline and considered well enough to participate in the study\n* Parent/caregiver is willing to consider nasogastric, nasojejunal, or gastrostomy tube placement during the study to maintain safe hydration, nutrition, and treatment delivery, if recommended by the investigator.\n\nExclusion Criteria:\n\n* Presence of clinical symptoms or signs consistent with SMA Type 0\n* In the opinion of the investigator, inadequate venous or capillary blood access for the study procedures\n* Systolic blood pressure or diastolic blood pressure or heart rate abnormalities\n* Presence of clinically relevant electrocardiogram (ECG) abnormalities\n* The infant (or the person breastfeeding the infant) taking any of the following: any inhibitor of CYP3A4 taken within 2 weeks (or within 5 times the elimination half-life, whichever is longer) prior to dosing, any inducer of CYP3A4 taken within 4 weeks (or within 5 times the elimination half-life, whichever is longer prior to dosing, and/or use of any multidrug and toxin extrusion (MATE) substrates taken within 2 weeks (or within 5 times the elimination half-life, whichever is longer) prior to dosing\n* Concurrent or previous administration of nusinersen or onasemnogene abeparvovec\n* Clinically significant abnormalities in laboratory test",
            "healthyVolunteers": false,
            "sex": "ALL",
            "maximumAge": "19 Days",
            "stdAges": [
                "CHILD"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Reference Study ID Number: BN44619 https://forpatients.roche.com/",
                    "role": "CONTACT",
                    "phone": "888-662-6728 (U.S. Only)",
                    "email": "global-roche-genentech-trials@gene.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Clinical Trials",
                    "affiliation": "Hoffmann-La Roche",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Ann and Robert H. Lurie Children Hospital of Chicago",
                    "status": "RECRUITING",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60611",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                },
                {
                    "facility": "University Of Michigan; Pediatric Nephrology",
                    "status": "RECRUITING",
                    "city": "Ann Arbor",
                    "state": "Michigan",
                    "zip": "48109",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.27756,
                        "lon": -83.74088
                    }
                },
                {
                    "facility": "Hopital Universitaire des Enfants Reine Fabiola",
                    "status": "RECRUITING",
                    "city": "Bruxelles",
                    "zip": "1020",
                    "country": "Belgium",
                    "geoPoint": {
                        "lat": 50.85045,
                        "lon": 4.34878
                    }
                },
                {
                    "facility": "UZA",
                    "status": "WITHDRAWN",
                    "city": "Edegem",
                    "zip": "2650",
                    "country": "Belgium",
                    "geoPoint": {
                        "lat": 51.15662,
                        "lon": 4.44504
                    }
                },
                {
                    "facility": "Universitatsklinikum Essen",
                    "status": "RECRUITING",
                    "city": "Essen",
                    "zip": "45147",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 51.45657,
                        "lon": 7.01228
                    }
                },
                {
                    "facility": "Fondazione Serena Onlus - CENTRO CLINICO NEMO",
                    "status": "RECRUITING",
                    "city": "Milano",
                    "state": "Emilia-Romagna",
                    "zip": "20162",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 45.46427,
                        "lon": 9.18951
                    }
                },
                {
                    "facility": "Instytut Pomnik - Centrum Zdrowia Dziecka; Apteka Szpitalna",
                    "status": "RECRUITING",
                    "city": "Warszawa",
                    "zip": "04-730",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 52.22977,
                        "lon": 21.01178
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "Qualified researchers may request access to individual patient level data through the clinical study data request platform (www.vivli.org). Further details on Roche's criteria for eligible studies are available here (https://vivli.org/ourmember/roche/). For further details on Roche's Global Policy on the Sharing of Clinical Information and how to request access to related clinical study documents, see here (https://www.roche.com/research_and_development/who_we_are_how_we_work/clinical_trials/our_commitment_to_data_sharing.htm)."
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009133",
                    "term": "Muscular Atrophy"
                },
                {
                    "id": "D000009134",
                    "term": "Muscular Atrophy, Spinal"
                },
                {
                    "id": "D000001284",
                    "term": "Atrophy"
                }
            ],
            "ancestors": [
                {
                    "id": "D000020763",
                    "term": "Pathological Conditions, Anatomical"
                },
                {
                    "id": "D000020879",
                    "term": "Neuromuscular Manifestations"
                },
                {
                    "id": "D000009461",
                    "term": "Neurologic Manifestations"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000013118",
                    "term": "Spinal Cord Diseases"
                },
                {
                    "id": "D000002493",
                    "term": "Central Nervous System Diseases"
                },
                {
                    "id": "D000016472",
                    "term": "Motor Neuron Disease"
                },
                {
                    "id": "D000019636",
                    "term": "Neurodegenerative Diseases"
                },
                {
                    "id": "D000009468",
                    "term": "Neuromuscular Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4589",
                    "name": "Atrophy",
                    "asFound": "Atrophy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12090",
                    "name": "Muscular Atrophy",
                    "asFound": "Muscular Atrophy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12091",
                    "name": "Muscular Atrophy, Spinal",
                    "asFound": "Muscular Atrophy, Spinal",
                    "relevance": "HIGH"
                },
                {
                    "id": "M22519",
                    "name": "Pathological Conditions, Anatomical",
                    "relevance": "LOW"
                },
                {
                    "id": "M22619",
                    "name": "Neuromuscular Manifestations",
                    "relevance": "LOW"
                },
                {
                    "id": "M12404",
                    "name": "Neurologic Manifestations",
                    "relevance": "LOW"
                },
                {
                    "id": "M15915",
                    "name": "Spinal Cord Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5742",
                    "name": "Central Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M18879",
                    "name": "Motor Neuron Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "M4024",
                    "name": "Amyotrophic Lateral Sclerosis",
                    "relevance": "LOW"
                },
                {
                    "id": "M21558",
                    "name": "Neurodegenerative Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12411",
                    "name": "Neuromuscular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T5342",
                    "name": "Spinal Muscular Atrophy",
                    "asFound": "Spinal Muscular Atrophy",
                    "relevance": "HIGH"
                },
                {
                    "id": "T349",
                    "name": "Amyotrophic Lateral Sclerosis",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000629884",
                    "term": "Risdiplam"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009465",
                    "term": "Neuromuscular Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M264314",
                    "name": "Risdiplam",
                    "asFound": "Streptococcus salivarius",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}